I agree that this site is using cookies. You can find further informations here.
X
Hermans, Cédric
765  results:
Search for persons X
?
1

Long-term outcomes with emicizumab in hemophilia A without ..:

Mahlangu, Johnny ; Jiménez-Yuste, Víctor ; Ventriglia, Giuliana...
Research and Practice in Thrombosis and Haemostasis.  8 (2024)  2 - p. 102364 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Direct oral anticoagulants and venous malformations: litera..:

Lagneaux, Eugénie ; Boon, Laurence M. ; Revencu, Nicole..
Research and Practice in Thrombosis and Haemostasis.  8 (2024)  3 - p. 102400 , 2024
Link: https://doi.org/10.1016/..
 
?
3

The effectiveness and safety of octocog alfa in patients wi..:

Ozelo, Margareth C. ; Hermans, Cedric ; Carcao, Manuel...
Therapeutic Advances in Hematology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
4

Inhibitor development according to concentrate after 50 exp..:

Fischer, Kathelijn ; Lassila, Riitta ; Peyvandi, Flora...
Research and Practice in Thrombosis and Haemostasis.  8 (2024)  4 - p. 102461 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Eptacog beta for the management of patients with haemophili..:

Miesbach, Wolfgang ; Carcao, Manuel ; Mahlangu, Johnny...
Haemophilia.  30 (2024)  2 - p. 257-266 , 2024
Link: https://doi.org/10.1111/..
 
?
6

Ultra-Long factor VIII: a major step forward toward a hemop..:

Hermans, Cedric ; Pierce, Glenn F.
Journal of Thrombosis and Haemostasis.  22 (2024)  7 - p. 1844-1846 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Moving towards Normalization of haemostasis and health equi..:

Holme, Pål André ; Blatný, Jan ; Chowdary, Pratima...
Haemophilia.  , 2024
Link: https://doi.org/10.1111/..
 
?
8

Targeted Treatments for Vascular Malformations: Current Sta..:

SERONT, Emmanuel ; HERMANS, Cedric ; BOON, Laurence M..
Journal of Thrombosis and Haemostasis.  , 2024
Link: https://doi.org/10.1016/..
 
?
9

Von Willebrand factor as a potential predictive biomarker o..:

Dachy, Guillaume ; Vankeerbergen, Marine ; Vanlangendonck, Nicolas...
Bone Marrow Transplantation.  59 (2024)  6 - p. 890-892 , 2024
Link: https://doi.org/10.1038/..
 
?
10

Low‐dose emicizumab for more equitable access to prophylaxi..:

Mannucci, Pier Mannuccio ; Hermans, Cedric
Haemophilia.  , 2024
Link: https://doi.org/10.1111/..
 
?
11

The association between unemployment and treatment among ad..:

Qvigstad, Christian ; Sørensen, Lars Q. ; Tjønnfjord, Geir E....
Research and Practice in Thrombosis and Haemostasis.  8 (2024)  5 - p. 102514 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Risk of harm to people with haemophilia from the 2023 WHO E..:

Pierce, Glenn F ; O'Mahony, Brian ; Kaczmarek, Radoslaw...
The Lancet Haematology.  , 2024
Link: https://doi.org/10.1016/..
 
?
13

Transitioning from emicizumab prophylaxis to valoctocogene ..:

Agarwal, Suresh ; Hermans, Cedric ; Miesbach, Wolfgang...
Haemophilia.  30 (2024)  4 - p. 905-913 , 2024
Link: https://doi.org/10.1111/..
 
?
14

Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Ve..:

Meier, Niklaus ; Fuchs, Hendrik ; Galactionova, Katya...
PharmacoEconomics - Open.  8 (2024)  3 - p. 373-387 , 2024
Link: https://doi.org/10.1007/..
 
?
15

Reliability and construct validity of the ACTIVLIM‐Hemo and..:

Lobet, Sébastien ; Hermans, Cedric ; Chantrain, Valérie‐Anne...
Haemophilia.  30 (2024)  2 - p. 497-504 , 2024
Link: https://doi.org/10.1111/..
 
1-15